Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Influenza Vaccine in Regular vs Irregular Vaccinators
NCT02876159Phase 4Completed
- Sponsor
- Emory University
- Start
- Jul 2016
- Primary completion
- Oct 2016
- Countries
- 1
01
Overview
A Phase 4 trial of Influenza vaccine (2016-2017 formulation) in influenza, sponsored by Emory University. Started Jul 2016; status: completed.
02
Drugs
Influenza vaccine (2016-2017 formulation)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02876159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02876159.